Treatment of Hemophilia A with a Highly Purified Factor VIII Concentrate Prepared
by Anti-FVIIIc Immunoaffinity Chromatography
Authors
Joseph E Addiego Jr.
The Children’s Hospital Medical Center of Northern California; Children’s Hospital
Los Angeles; Baxter Healthcare Corporation, Hyland Division, Glendale, CA, USA
Edward Gomperts
The Children’s Hospital Medical Center of Northern California; Children’s Hospital
Los Angeles; Baxter Healthcare Corporation, Hyland Division, Glendale, CA, USA
Liu Shu-Len
The Children’s Hospital Medical Center of Northern California; Children’s Hospital
Los Angeles; Baxter Healthcare Corporation, Hyland Division, Glendale, CA, USA
Patricia Bailey
The Children’s Hospital Medical Center of Northern California; Children’s Hospital
Los Angeles; Baxter Healthcare Corporation, Hyland Division, Glendale, CA, USA
Suzanne G Courter
The Children’s Hospital Medical Center of Northern California; Children’s Hospital
Los Angeles; Baxter Healthcare Corporation, Hyland Division, Glendale, CA, USA
Martin L Lee
The Children’s Hospital Medical Center of Northern California; Children’s Hospital
Los Angeles; Baxter Healthcare Corporation, Hyland Division, Glendale, CA, USA
Gerald G Neslund
The Children’s Hospital Medical Center of Northern California; Children’s Hospital
Los Angeles; Baxter Healthcare Corporation, Hyland Division, Glendale, CA, USA
Henry S Kingdon
The Children’s Hospital Medical Center of Northern California; Children’s Hospital
Los Angeles; Baxter Healthcare Corporation, Hyland Division, Glendale, CA, USA
Michael J Griffith
The Children’s Hospital Medical Center of Northern California; Children’s Hospital
Los Angeles; Baxter Healthcare Corporation, Hyland Division, Glendale, CA, USA